Impact of Different Lines of Palliative Chemotherapy in Patients with Metastatic Breast Cancer

Study of Outcome of Early Breast Cancer Patients Treated with Different Chemotherapy Protocols

Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine as First-Line Therapy for Metastatic Triple Negative Breast Cancer

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

PLATINUM BASED VERSUS ANTHRACYCLIN BASED NEOADJUVANT CHEMOTHERAPY IN NONMETASTATIC TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer

Comparative study of docetaxel versus paclitaxel inmetastatic breast cancer patients

Outcome of liver resection in breast cancer liver metastases

Evaluation of the Effect of Combination Chemotherapy with Five-day Infusion of Fluorouracil plus Vinorelbine in Pretreated Metastatic Breast Cancer Patients

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer